Next Article in Journal
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation
Next Article in Special Issue
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial
Previous Article in Journal
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
Previous Article in Special Issue
What Drives the Value of a Shigella Vaccine?
 
 
Review

Article Versions Notes

Vaccines 2022, 10(2), 328; https://doi.org/10.3390/vaccines10020328
Action Date Notes Link
article xml file uploaded 18 February 2022 11:39 CET Original file -
article xml uploaded. 18 February 2022 11:39 CET Update https://www.mdpi.com/2076-393X/10/2/328/xml
article pdf uploaded. 18 February 2022 11:39 CET Version of Record https://www.mdpi.com/2076-393X/10/2/328/pdf
article html file updated 18 February 2022 11:40 CET Original file -
article html file updated 31 July 2022 22:31 CEST Update https://www.mdpi.com/2076-393X/10/2/328/html
Back to TopTop